GI
ATYR

GAMMA Investing’s aTyr Pharma ATYR Stock Holding History

GAMMA Investing’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393 Sell
659
-7,080
-91% -$4.63K ﹤0.01% 4020
2026
Q1 		$6.04K Buy
+7,739
New +$6.53K ﹤0.01% 3297

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GAMMA Investing's ATYR Position: Q2 2026 in Review

GAMMA Investing reduced its aTyr Pharma (ATYR) stake by 91% in Q2 2026, selling an estimated $4.63K and leaving 659 shares worth $393. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

GAMMA Investing first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.04K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • GAMMA Investing held 659 shares of aTyr Pharma worth $393 as of Q2 2026.
  • GAMMA Investing sold 7,080 aTyr Pharma shares in Q2 2026, an estimated $4.63K.
  • aTyr Pharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4020 holding.
  • GAMMA Investing first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • GAMMA Investing's aTyr Pharma position peaked at $6.04K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.